Andrew Bottomley

1995–2025 年に発表

124
論文数
21,237
被引用数
81
h 指数
118
i10 指数

被引用数

Andrew Bottomley の年別被引用数1996 年: 被引用 1 件1997 年: 被引用 6 件1998 年: 被引用 7 件1999 年: 被引用 5 件2000 年: 被引用 16 件2001 年: 被引用 6 件2002 年: 被引用 18 件2003 年: 被引用 30 件2004 年: 被引用 45 件2005 年: 被引用 70 件2006 年: 被引用 64 件2007 年: 被引用 112 件2008 年: 被引用 95 件2009 年: 被引用 115 件2010 年: 被引用 121 件2011 年: 被引用 162 件2012 年: 被引用 143 件2013 年: 被引用 179 件2014 年: 被引用 131 件2015 年: 被引用 125 件2016 年: 被引用 139 件2017 年: 被引用 144 件2018 年: 被引用 144 件2019 年: 被引用 677 件2020 年: 被引用 684 件2021 年: 被引用 573 件2022 年: 被引用 471 件2023 年: 被引用 296 件2024 年: 被引用 646 件2025 年: 被引用 246 件2026 年: 被引用 7 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,383 件、この内訳の 15%イギリス: 引用元論文 841 件、この内訳の 9.1%オランダ: 引用元論文 709 件、この内訳の 7.7%ドイツ: 引用元論文 672 件、この内訳の 7.3%イタリア: 引用元論文 488 件、この内訳の 5.3%フランス: 引用元論文 436 件、この内訳の 4.7%オーストラリア: 引用元論文 409 件、この内訳の 4.4%カナダ: 引用元論文 408 件、この内訳の 4.4%ベルギー: 引用元論文 347 件、この内訳の 3.7%スペイン: 引用元論文 294 件、この内訳の 3.2%中国: 引用元論文 279 件、この内訳の 3%スウェーデン: 引用元論文 252 件、この内訳の 2.7%
0%15%その他 29.5%

分野

  • Medicine85.2%
  • Biochemistry, Genetics and Molecular Biology3.2%
  • Economics, Econometrics and Finance2.7%
  • Health Professions2.3%
  • Psychology1.6%
  • Social Sciences0.8%
  • その他4.2%

トピック

  • Cancer survivorship and care11.9%
  • Brain Metastases and Treatment3.1%
  • Glioma Diagnosis and Treatment3.1%
  • Cancer-related cognitive impairment studies3.1%
  • Palliative Care and End-of-Life Issues2.1%
  • Childhood Cancer Survivors' Quality of Life2.1%
  • その他74.6%

共著者

全論文

検索で開く
  1. EORTC QLQ-C30 Scoring Manual

    著者: , , , , , - 1995 被引用: 2,421

  2. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Brundage, Michael Palmer, Paul G. Kluetz, Richard Stephens, Robert Golub, Sandra A. Mitchell, Trish Groves - JAMA 2018 被引用: 798

  3. Quality of life research within the EORTC—the EORTC QLQ-C30

    著者: , - European Journal of Cancer 2002 被引用: 915

  4. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashley Wilder Smith, Katherine M Soltys, Martin Taphoorn, Galina Velikova, Andrew Bottomley - The Lancet Oncology 2020 被引用: 306

  5. Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types

    著者: , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2023 被引用: 174

  6. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

    著者: , , , , , , , , - The Lancet Oncology 2009 被引用: 653

  7. Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer

    著者: , , , , , , , , , , , , , , , , , - European Journal of Cancer 2022 被引用: 157

  8. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elektra J. Papadopoulos, Kavita Sail, Rohini Sen, Sean Turner, Kim Cocks, Jaap C. Reijneveld, Christoph Gerlinger, Karen Keating, Yun Su, Birgit Wolf, Miaomiao Ge, Anders Ingelgaard, Barbara Peil, Maarten Voorhaar, Brendon Wong, Gracia Dekanic Arbanas, Karin Kuljanić, Duška Petranović, Ivana Rede, Juan Ignacio Arrarás, Stephen Joel Coons, Sonya Eremenco, Lindsey Murray, Bryce B. Reeve, Corinne S de Vries, Ralf Herold, Francesco Pignatti, Abigirl Machingura, Francesca Martinelli, Jammbe Musoro, Martine Piccart, Jorge Barriuso, Nathan I. Cherny, Urania Dafni, Elisabeth G.E. de Vries, Bishal Gyawali, Barbara Kiesewetter, Sjoukje F. Oosting, Felipe Roitberg, Gerhard Rumpold, Felix Schoepf, Michael Tschuggnall, Jennifer A. Black, Maxime Sasseville, Katherine M Soltys, Montserrat Ferrer, Olatz Garín, Gemma Vilagut, Christoph Schürmann, Stefanie M. Thomas, Beate Wieseler, Claire Snyder, Ariel Alonso Abad, Kris Bogaerts, Febe Brackx, Geert Molenberghs, Geert Verbeke, Cristián Frigolett Catalan, Jan Choi, Doranne Thomassen, Jan Geißler, Willi Sauerbrei, Franziska Gross, Micha J. Pilz, Yolanda Barbáchano, Lisa Campbell, Khadija Rantell, Gregoire Desplanques, Antoine Regnault, Kate Morgan ほか 41 名 - The Lancet Oncology 2023 被引用: 57

  9. Recommendations to address respondent burden associated with patient-reported outcome assessment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Khadija Rantell, Antoine Regnault, Maxime Sasseville, Liv Marit Valen Schougaard, Roya Sherafat‐Kazemzadeh, Claire Snyder, Angela M. Stover, Rav Verdi, Roger Wilson, Melanie Calvert - Nature Medicine 2024 被引用: 116

  10. The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care

    著者: , , , , , , , , , , , - European Journal of Cancer 2005 被引用: 689

  11. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

    著者: , , , , , , , , , - European Journal of Cancer 2010 被引用: 392

  12. The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials

    著者: , , , - Journal of Clinical Oncology 2008 被引用: 655

  13. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12)

    著者: , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2016 被引用: 184

  14. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Koller, Eva Nagele, Ourania Nicolatou‐Galitis, Anne Oberguggenberger, Claudia Schmalz, Zoë Winters - Annals of Oncology 2020 被引用: 145

  15. Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 68

  16. Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer

    著者: , , , , , , , , , , , , , - JNCI Cancer Spectrum 2019 被引用: 114

  17. Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials

    著者: , , , , , , , , , , , , , , , - Cancer 2018 被引用: 99

  18. Linking the European Organisation for Research and Treatment of Cancer Item Library to the Common Terminology Criteria for Adverse Events

    著者: , , , , , , - Journal of Clinical Oncology 2022 被引用: 55

  19. A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 645

  20. An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer

    著者: , , , , , , , , , , , - European Journal of Cancer 2008 被引用: 485

  21. Current state of quality of life and patient-reported outcomes research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anne‐Sophie Darlington, Ian Lewis, Lonneke V. van de Poll‐Franse - European Journal of Cancer 2019 被引用: 178

  22. Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review

    著者: , , , , , , , , , , , , - The Lancet Oncology 2019 被引用: 129

  23. Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer

    著者: , , , , , , , , , , , , , , , - European Journal of Cancer 2019 被引用: 75

  24. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michal Kiciński, Stefan Suciu, Caroline Robert, Alexander M.M. Eggermont, Thierry Lesimple, Michele Maio, Gerald P. Linette, Laurent Mortier, Inge Marie Svane, Jacob Schachter, Michael P. Brown, Peter Hersey, Catherine Barrow, Ragini R. Kudchadkar, Caroline Dutriaux, Xinni Song, Pietro Quaglino, Paola Queirolo, Friedegund Meier, Daniil Stroyakovskiy, B. Guillot, Pablo L. Ortiz‐Romero, Lars Bastholt, Claus Garbe, Florent Grange, Peter Mohr, Alain P. Algazi, Oliver Bechter, Micaela Hernberg, Carmen Loquai, Frank Meiß, Vanna Chiarion‐Sileni, Gil Bar‐Sela, Bernard M. Fitzharris, Philippe Saïag, Jean‐Philippe Arnault, Jan‐Christoph Simon, Rosalie Stephens, Jean‐François Baurain, Célèste Lebbé, P. Combemale, Reinhard Dummer, Axel Hauschild, Phillip Parente, Naoya Yamazaki, Mohammed Milhem, M.‐T. Leccia, L. Geoffrois, Lutz Kretschmer, Elaine Dunwoodie, John Walker, Michal Lotem, Daniel Hendler, Andrzej Maćkiewicz, Lidija Kandolf Sekulović, Marcin Dzienis, Geke A.P. Hospers, Marco Siano, Jessica C. Hassel, Philippa Corrie, Maria-Jose Passos, Max Levin, Christoph Höeller, L. Machet, Sigrun Hallmeyer, Ashita Waterston, V. Descamps, Felix Kiecker, Maureen J.B. Aarts, Henrik Schmidt ほか 34 名 - The Lancet Oncology 2021 被引用: 72